Prevention of microgliosis halts early memory loss in a mouse model of Alzheimer’s disease

[1]  E. Hol,et al.  Amyloid‐β plaques affect astrocyte Kir4.1 protein expression but not function in the dentate gyrus of APP/PS1 mice , 2022, Glia.

[2]  Laurent F. Thomas,et al.  A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease , 2021, Nature Genetics.

[3]  I. Bechmann,et al.  Classification of Microglial Morphological Phenotypes Using Machine Learning , 2021, Frontiers in Cellular Neuroscience.

[4]  A. Nimmerjahn,et al.  Microglia use TAM receptors to detect and engulf amyloid beta plaques , 2021, Nature Immunology.

[5]  D. Borchelt,et al.  Reactive astrocytes as treatment targets in Alzheimer's disease—Systematic review of studies using the APPswePS1dE9 mouse model , 2021, Glia.

[6]  J. Mulder,et al.  Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease , 2021, Acta Neuropathologica.

[7]  B. Eggen,et al.  Intrinsic DNA damage repair deficiency results in progressive microglia loss and replacement , 2020, Glia.

[8]  D. Shippy,et al.  Microglial Immunometabolism in Alzheimer’s Disease , 2020, Frontiers in Cellular Neuroscience.

[9]  N. Harrison,et al.  Minocycline differentially modulates human spatial memory systems , 2020, Neuropsychopharmacology.

[10]  Jie Li,et al.  Microglia mediate forgetting via complement-dependent synaptic elimination , 2020, Science.

[11]  S. Reeves,et al.  Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease , 2019, JAMA neurology.

[12]  Caroline L C Neely,et al.  Nest Building Behavior as an Early Indicator of Behavioral Deficits in Mice. , 2019, Journal of visualized experiments : JoVE.

[13]  I. Heuser,et al.  Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner , 2019, Translational Psychiatry.

[14]  P. Scheltens,et al.  Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer’s disease , 2019, Molecular Psychiatry.

[15]  H. Mansvelder,et al.  Gpr158 Deficiency Impacts Hippocampal CA1 Neuronal Excitability, Dendritic Architecture, and Affects Spatial Learning , 2018, bioRxiv.

[16]  B. Stevens,et al.  Microglia and the Brain: Complementary Partners in Development and Disease. , 2018, Annual review of cell and developmental biology.

[17]  B. Eggen,et al.  The Kaleidoscope of Microglial Phenotypes , 2018, Front. Immunol..

[18]  P. Scheltens,et al.  Neuropathology and cognitive performance in self-reported cognitively healthy centenarians , 2018, Acta neuropathologica communications.

[19]  Sterling C. Johnson,et al.  Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia , 2018, Neurology.

[20]  B. Winblad,et al.  APP mouse models for Alzheimer's disease preclinical studies , 2017, The EMBO journal.

[21]  Beth Stevens,et al.  Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice , 2017, Science Translational Medicine.

[22]  P. Brust,et al.  Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment , 2017, Translational Psychiatry.

[23]  Yanbo Zhang,et al.  The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease , 2017, CNS neuroscience & therapeutics.

[24]  E. Hol,et al.  Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease. , 2016, Biochimica et biophysica acta.

[25]  A. Fischer,et al.  Ly6C(hi) Monocytes Provide a Link between Antibiotic-Induced Changes in Gut Microbiota and Adult Hippocampal Neurogenesis. , 2016, Cell reports.

[26]  Ben A. Barres,et al.  Complement and microglia mediate early synapse loss in Alzheimer mouse models , 2016, Science.

[27]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[28]  O. Heikal,et al.  Minocycline attenuates Aβ oligomers-induced pro-inflammatory phenotype in primary microglia while enhancing Aβ fibrils phagocytosis , 2015, Neuroscience Letters.

[29]  Emmeke Aarts,et al.  The light spot test: Measuring anxiety in mice in an automated home-cage environment , 2015, Behavioural Brain Research.

[30]  Jeremy A. Miller,et al.  Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis , 2015, Acta Neuropathologica Communications.

[31]  V. Perry,et al.  Microglial Dynamics and Role in the Healthy and Diseased Brain , 2015, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[32]  L. Tan,et al.  Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. , 2015, Annals of translational medicine.

[33]  E. Weeber,et al.  Slingshot-Cofilin activation mediates mitochondrial and synaptic dysfunction via Aβ ligation to β1-integrin conformers , 2015, Cell Death and Differentiation.

[34]  E. Hol,et al.  Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction , 2014, Neurobiology of Aging.

[35]  C. Eroglu,et al.  Rapid Golgi Analysis Method for Efficient and Unbiased Classification of Dendritic Spines , 2014, PloS one.

[36]  M. Lynch,et al.  Modulation of Intestinal Microbiota by the Probiotic VSL#3 Resets Brain Gene Expression and Ameliorates the Age-Related Deficit in LTP , 2014, PloS one.

[37]  H. Mansvelder,et al.  Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer’s disease , 2014, Acta neuropathologica communications.

[38]  Deacon Rmj.  A Novel Approach to Discovering Treatments for Alzheimer's Disease , 2014 .

[39]  Joseph P. Garner,et al.  Nest Building as an Indicator of Health and Welfare in Laboratory Mice , 2013, Journal of visualized experiments : JoVE.

[40]  Val Lowe,et al.  Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. , 2013, Brain : a journal of neurology.

[41]  F. Kirchhoff,et al.  Microglia: New Roles for the Synaptic Stripper , 2013, Neuron.

[42]  Paul Edison,et al.  Drug repositioning for Alzheimer's disease , 2012, Nature Reviews Drug Discovery.

[43]  H. Steinbusch,et al.  Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer’s disease , 2012, Neurochemistry International.

[44]  Ming-gao Zhao,et al.  Involvement of Microglia Activation in the Lead Induced Long-Term Potentiation Impairment , 2012, PloS one.

[45]  Ben A. Barres,et al.  Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner , 2012, Neuron.

[46]  O. Lindvall,et al.  Inhibition of Microglial Activation Protects Hippocampal Neurogenesis and Improves Cognitive Deficits in a Transgenic Mouse Model for Alzheimer’s Disease , 2012, Neurodegenerative Diseases.

[47]  M. Ferretti,et al.  Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology , 2012, Journal of Neuroinflammation.

[48]  E. Hol,et al.  Differential cell proliferation in the cortex of the appsweps1de9 alzheimer's disease mouse model , 2012, Glia.

[49]  A. Nimmerjahn,et al.  The Role of Microglia in the Healthy Brain , 2011, The Journal of Neuroscience.

[50]  J. DeFelipe,et al.  Layer‐specific alterations to CA1 dendritic spines in a mouse model of Alzheimer's disease , 2011, Hippocampus.

[51]  M. Giustetto,et al.  Synaptic Pruning by Microglia Is Necessary for Normal Brain Development , 2011, Science.

[52]  Hélène Marie,et al.  Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models? , 2011, Alzheimer's & Dementia.

[53]  H. Marie,et al.  Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models? , 2011, Alzheimer's & Dementia.

[54]  M. Lynch,et al.  Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction , 2011, Journal of neurochemistry.

[55]  M. Jensen,et al.  Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1ΔE9-deleted transgenic mice model of β-amyloidosis , 2010, Neurobiology of Aging.

[56]  G. Landreth,et al.  The role of microglia in amyloid clearance from the AD brain , 2010, Journal of Neural Transmission.

[57]  Y. Antonenko,et al.  Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels , 2010, Journal of bioenergetics and biomembranes.

[58]  S. Rivest,et al.  Cognitive and non‐cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer’s disease , 2009, Genes, brain, and behavior.

[59]  J. Koistinaho,et al.  Minocycline reduces engraftment and activation of bone marrow‐derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease , 2008, Glia.

[60]  M. Block,et al.  Retinoic Acid Attenuates β-Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model , 2008, The Journal of Neuroscience.

[61]  J. Rawlins,et al.  Age-dependent and -independent behavioral deficits in Tg2576 mice , 2008, Behavioural Brain Research.

[62]  J. Deleo,et al.  Minocycline decreases in vitro microglial motility, β1‐integrin, and Kv1.3 channel expression , 2007, Journal of neurochemistry.

[63]  Yoo-Hun Suh,et al.  Minocycline Attenuates Neuronal Cell Death and Improves Cognitive Impairment in Alzheimer's Disease Models , 2007, Neuropsychopharmacology.

[64]  Judianne Davis,et al.  Minocycline Reduces Microglial Activation and Improves Behavioral Deficits in a Transgenic Model of Cerebral Microvascular Amyloid , 2007, The Journal of Neuroscience.

[65]  A. Bessis,et al.  Microglial control of neuronal death and synaptic properties , 2007, Glia.

[66]  M. Lynch,et al.  The age‐related attenuation in long‐term potentiation is associated with microglial activation , 2006, Journal of neurochemistry.

[67]  R. Deacon.  Assessing nest building in mice , 2006, Nature Protocols.

[68]  F. Schmitt,et al.  Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment , 2006, Neurobiology of Aging.

[69]  C. Lemere,et al.  Minocycline affects microglia activation, Aβ deposition, and behavior in APP‐tg mice , 2006, Glia.

[70]  Mark Bowlby,et al.  Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[71]  R. Veerhuis,et al.  Inhibitory effect of minocycline on amyloid β fibril formation and human microglial activation , 2006, Glia.

[72]  R. Anwyl,et al.  β‐amyloid inhibition of long‐term potentiation is mediated via tumor necrosis factor , 2005 .

[73]  J. Brotchi,et al.  Clinical potential of minocycline for neurodegenerative disorders , 2004, Neurobiology of Disease.

[74]  C. Power,et al.  For Personal Use. Only Reproduce with Permission from Elsevier Ltd Minocycline and Neurological Diseases Minocycline in Animal Models the Promise of Minocycline in Neurology , 2022 .

[75]  D. Borchelt,et al.  APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1 , 2004, Neurobiology of Aging.

[76]  Robert A Edwards,et al.  Visible fluorescent detection of proteins in polyacrylamide gels without staining. , 2004, Analytical biochemistry.

[77]  S. Weggen,et al.  Evidence That Nonsteroidal Anti-inflammatory Drugs Decrease Amyloid β42 Production by Direct Modulation of γ-Secretase Activity* , 2003, Journal of Biological Chemistry.

[78]  J. Rawlins,et al.  Hippocampal cytotoxic lesion effects on species-typical behaviours in mice , 2002, Behavioural Brain Research.

[79]  George A. Carlson,et al.  The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[80]  Max A. Viergever,et al.  Quantitative evaluation of convolution-based methods for medical image interpolation , 2001, Medical Image Anal..

[81]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[82]  M. Reivich,et al.  ACTIVATION , 1980, The Social Value of Zoos.

[83]  A. Bacci,et al.  Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease , 2011, Nature Neuroscience.

[84]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[85]  F. LaFerla,et al.  Reductions in amyloid-beta-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation. , 2010, Journal of Alzheimer's disease : JAD.

[86]  F. LaFerla,et al.  Alzheimer's disease. , 2010, The New England journal of medicine.

[87]  J. Zeman,et al.  quantitative evaluation of by , 2010 .

[88]  E. Bedel.  Relationship between , 2009 .

[89]  S. Weggen,et al.  Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. , 2003, The Journal of biological chemistry.